The Hip
Home » Deep Venous Thrombosis (DVT) » DVT Risk Reduction – Hip Fracture

DVT Risk Reduction – Hip Fracture

choice of anesthesia

role of heparin

role of dextran


The thromboprophylactic effect of a low-molecular-weight heparin (Fragmin) in hip fracture surgery. A placebo-controlled study.

A prospective double-blind trial of a low molecular weight heparin once daily compared with conventional low-dose heparin three times daily to prevent pulmonary embolism and venous thrombosis in patients with hip fracture.

Low-dose heparin for prevention of venous thromboembolism in total hip arthroplasty and surgical repair of hip fractures.

Autopsy-verified major pulmonary embolism after hip fracture.

Efficacy and safety of rivaroxaban versus low-molecular-weight heparin therapy in patients with lower limb fractures.

Compression ultrasonography for the detection of deep venous thrombosis in patients who have a fracture of the hip. A prospective study.

Low-molecular-weight heparinoid compared with warfarin for prophylaxis of deep-vein thrombosis in patients who are operated on for fracture of the hip. A prospective, randomized trial.

Prevention of deep vein thrombosis after elective hip surgery. A randomized trial comparing low molecular weight heparin with standard unfractionated heparin.

Aspirin prophylaxis and surveillance of pulmonary embolism and deep vein thrombosis in total hip arthroplasty.

Prevention of fatal pulmonary embolism in patients with fractures of the neck of the femur.

See also
DVT overview
Pulmonary Embolism